Bladder Cancer Prognosis Using Deep Neural Networks and Histopathology Images
Title:
Bladder Cancer Prognosis Using Deep Neural Networks and Histopathology Images
Link:
https://www.sciencedirect.com/science/article/pii/S2153353922007295
Abstract:
Background Recent studies indicate that bladder cancer is among the top 10 most common cancers in the world (Saginala et al. 2022). Bladder cancer frequently reoccurs, and prognostic judgments may vary among clinicians. As a favorable prognosis may help to inform less aggressive treatment plans, classification of histopathology slides is essential for the accurate prognosis and effective treatment of bladder cancer patients. Developing automated and accurate histopathology image analysis methods can help pathologists determine the prognosis of patients with bladder cancer.
Materials and methods In this study, we introduced Bladder4Net, a deep learning pipeline, to classify whole-slide histopathology images of bladder cancer into two classes: low-risk (combination of PUNLMP and low-grade tumors) and high-risk (combination of high-grade and invasive tumors). This pipeline consists of four convolutional neural network (CNN)-based classifiers to address the difficulties of identifying PUNLMP and invasive classes. We evaluated our pipeline on 182 independent whole-slide images from the New Hampshire Bladder Cancer Study (NHBCS) (Karagas et al., 1998; Sverrisson et al., 2014; Sverrisson et al., 2014) collected from 1994 to 2004 and 378 external digitized slides from The Cancer Genome Atlas (TCGA) database (https://www.cancer.gov/tcga).
Results The weighted average F1-score of our approach was 0.91 (95% confidence interval (CI): 0.86–0.94) on the NHBCS dataset and 0.99 (95% CI: 0.97–1.00) on the TCGA dataset. Additionally, we computed Kaplan–Meier survival curves for patients who were predicted as high risk versus those predicted as low risk. For the NHBCS test set, patients predicted as high risk had worse overall survival than those predicted as low risk, with a log-rank p-value of 0.004.
Conclusions If validated through prospective trials, our model could be used in clinical settings to improve patient care.
Citation:
Wayner Barrios, Behnaz Abdollahi, Manu Goyal, Qingyuan Song, Matthew Suriawinata, Ryland Richards, Bing Ren, Alan Schned, John Seigne, Margaret Karagas, Saeed Hassanpour, “Bladder Cancer Prognosis Using Deep Neural Networks and Histopathology Images”, Journal of Pathology Informatics, 13,
